August 26, 2015
Chugai Pharmaceutical said on August 24 that it has filed a public knowledge-based application for its immunosuppressant CellCept Capsules 250 (mycophenolate mofetil) for an additional indication of lupus nephritis. Lupus nephritis is a designated intractable disease in Japan, and the...read more